Homo sapiens Protein: PRKAR1A
Summary
InnateDB Protein IDBP-245106.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol PRKAR1A
Protein Name protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
Synonyms ACRDYS1; ADOHR; CAR; CNC; CNC1; PKR1; PPNAD1; PRKAR1; TSE1;
Species Homo sapiens
Ensembl Protein ENSP00000376474
InnateDB Gene IDBG-65907 (PRKAR1A)
Protein Structure
UniProt Annotation
Function Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. {ECO:0000269PubMed:16491121, ECO:0000269PubMed:20215566}.
Subcellular Localization Cell membrane {ECO:0000269PubMed:23115245}.
Disease Associations Carney complex 1 (CNC1) [MIM:160980]: CNC is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumors, and psammomatous melanotic schwannomas. {ECO:0000269PubMed:15371594, ECO:0000269PubMed:18241045, ECO:0000269PubMed:22785148, ECO:0000269PubMed:23323113}. Note=The disease is caused by mutations affecting the gene represented in this entry.Intracardiac myxoma (INTMYX) [MIM:255960]: Inheritance is autosomal recessive. Note=The disease is caused by mutations affecting the gene represented in this entry.Primary pigmented nodular adrenocortical disease 1 (PPNAD1) [MIM:610489]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. PPNAD1 is most often diagnosed in patients with Carney complex, a multiple neoplasia syndrome. However it can also be observed in patients without other manifestations. {ECO:0000269PubMed:12213893}. Note=The disease is caused by mutations affecting the gene represented in this entry.Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]: A form of skeletal dysplasia characterized by short stature, severe brachydactyly, facial dysostosis, and nasal hypoplasia. Affected individuals often have advanced bone age and obesity. Laboratory studies show resistance to multiple hormones, including parathyroid, thyrotropin, calcitonin, growth hormone-releasing hormone, and gonadotropin. However, not all patients show endocrine abnormalities. {ECO:0000269PubMed:21651393, ECO:0000269PubMed:22464250, ECO:0000269PubMed:22464252, ECO:0000269PubMed:22723333, ECO:0000269PubMed:23043190, ECO:0000269PubMed:23425300}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity Four types of regulatory chains are found: I- alpha, I-beta, II-alpha, and II-beta. Their expression varies among tissues and is in some cases constitutive and in others inducible.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 92 experimentally validated interaction(s) in this database.
They are also associated with 5 interaction(s) predicted by orthology.
Experimentally validated
Total 92 [view]
Protein-Protein 89 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 3 [view]
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 5 [view]
Protein Structure and Domains
PDB ID
InterPro IPR003117 Dimerization-anchoring domain of cAMP-dependent protein kinase, regulatory subunit
PFAM PF02197
PRINTS
PIRSF
SMART SM00394
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-P10644
TrEMBL X6RAV4
UniProt Splice Variant
Entrez Gene 5573
UniGene Hs.733388
RefSeq
HUGO HGNC:9388
OMIM 188830
CCDS
HPRD 01786
IMGT
EMBL AC079210
GenPept